Impact of Xpert MTB/RIF and decentralized care on linkage to care and drug-resistant tuberculosis treatment outcomes in Johannesburg, South Africa

• Hauptverfasser: Denise Evans (Verfasst von), Tembeka Sineke (Verfasst von), Kathryn Schnippel (Verfasst von), Rebecca Berhanu (Verfasst von), Caroline Govathson (Verfasst von), Andrew Black (Verfasst von), Lawrence Long (Verfasst von), Sydney Rosen (Verfasst von)
• Format: Buch
• Veröffentlicht: BMC, 2018-12-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

Abstract Background In 2011, South Africa improved its ability to test for rifampicin-resistant TB (RR-TB) by introducing GeneXpert MTB/RIF. At the same time, the South African National TB program adopted a policy decentralized, outpatient treatment for drug resistant (DR-) TB. We aim to analyze the...